Literature DB >> 18577842

Memory impairment and awareness of memory deficits in early-stage Alzheimer's disease.

Masaru Mimura1.   

Abstract

In addition to their memory impairment, individuals with Alzheimer's disease (AD) often suffer from deficits in self-awareness. Awareness of memory deficits or metamemory is a multifaceted function, comprising on-line self-monitoring, generalized self-beliefs of memory efficacy, and generalized knowledge about memory functions. Awareness of memory problems in early-stage AD is a matter of clinical importance from a humanistic point of view, because higher levels of awareness may be associated with better future outcomes. Current methods of measuring awareness tend to fall into two categories, i.e., to introduce a questionnaire assessing patient/caregiver discrepancies; or to ask a patient to prospectively predict or retrospectively postdict their own memory performances. Characteristics of each measure as well as relationship between the two measures were discussed. For the performance prediction/postdiction paradigm, we used recognition memory of auditory verbal learning tests and awareness of memory deficits were examined in 24 individuals with early-stage AD. In addition to their significantly impaired recognition memory, individuals with AD displayed underawareness of memory deficits even at this early stage. They retrospectively overestimated memory performance after actual performance, but appeared to benefit from feedback and displayed intact on-line awareness of memory dysfunction, leading to normal prediction of the second session. However, individuals with AD again failed to retrospectively incorporate incidents of memory failure into generalized self-belief systems. Brain/behavior correlational analyses suggest that the prefrontal cortex and posterior dorsomedial regions including the precuneus may be involved in self-awareness.

Entities:  

Mesh:

Year:  2008        PMID: 18577842     DOI: 10.1620/tjem.215.133

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  7 in total

1.  Enhanced dendritic spine number of neurons of the prefrontal cortex, hippocampus, and nucleus accumbens in old rats after chronic donepezil administration.

Authors:  Faviola Alcantara-Gonzalez; Ismael Juarez; Oscar Solis; Isaura Martinez-Tellez; Israel Camacho-Abrego; Eliezer Masliah; Raul Mena; Gonzalo Flores
Journal:  Synapse       Date:  2010-10       Impact factor: 2.562

2.  Response bias for picture recognition in patients with Alzheimer disease.

Authors:  Ellen H Beth; Andrew E Budson; Jill D Waring; Brandon A Ally
Journal:  Cogn Behav Neurol       Date:  2009-12       Impact factor: 1.600

3.  Evaluation of Anosognosia in Alzheimer's Disease Using the Symptoms of Early Dementia-11 Questionnaire (SED-11Q).

Authors:  Yohko Maki; Tomoharu Yamaguchi; Haruyasu Yamaguchi
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2013-10-08

4.  Brain regions associated with anosognosia for memory disturbance in Alzheimer's disease: a magnetic resonance imaging study.

Authors:  Hiroshi Fujimoto; Teruyuki Matsuoka; Yuka Kato; Keisuke Shibata; Kaeko Nakamura; Kei Yamada; Jin Narumoto
Journal:  Neuropsychiatr Dis Treat       Date:  2017-07-05       Impact factor: 2.570

Review 5.  Self-awareness in Dementia: a Taxonomy of Processes, Overview of Findings, and Integrative Framework.

Authors:  Daniel C Mograbi; Jonathan Huntley; Hugo Critchley
Journal:  Curr Neurol Neurosci Rep       Date:  2021-11-24       Impact factor: 5.081

6.  Clinical correlates of awareness for balance, function, and memory: evidence for the modality specificity of awareness.

Authors:  Megan E O'Connell; Vanina Dal Bello-Haas; Margaret Crossley; Debra Morgan
Journal:  J Aging Res       Date:  2014-01-16

7.  Understanding Alzheimer's disease as a disorder of consciousness.

Authors:  Jonathan D Huntley; Stephen M Fleming; Daniel C Mograbi; Daniel Bor; Lorina Naci; Adrian M Owen; Robert Howard
Journal:  Alzheimers Dement (N Y)       Date:  2021-11-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.